1989
DOI: 10.1002/mds.870040507
|View full text |Cite
|
Sign up to set email alerts
|

A current analysis of behavioral problems in patients with idiopathic Parkinson's disease

Abstract: Parkinson's disease (PD) is a progressive disabling neurological disorder resulting from degeneration of dopamine-containing cells in the substantia nigra (1). Tremor, rigidity, bradykinesia, diminished hand and foot dexterity, and postural instability are the characteristic motor manifestations. Dementia, various forms of cognitive impairment, and depressive disorders are also present in PD (2). Although postmortem studies indicate that motor signs develop when 80% of the cells in the substantia nigra are los… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
6
0

Year Published

1992
1992
2004
2004

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 46 publications
0
6
0
Order By: Relevance
“…To explore the possibility that the association of dementia with mortality was related to withdrawal of levodopa (due to increased psychiatric side effects) 24 or to a hypothetical protective effect of selegiline on disease progression, 25,26 which might both delay the development of dementia and increase survival, we repeated the analysis controlling for use of levodopa and use of selegiline as time-dependent covariates in different models. We performed supplementary analyses designed to evaluate other possible confounders in the association of incident dementia with mortality in PD.…”
Section: Resultsmentioning
confidence: 99%
“…To explore the possibility that the association of dementia with mortality was related to withdrawal of levodopa (due to increased psychiatric side effects) 24 or to a hypothetical protective effect of selegiline on disease progression, 25,26 which might both delay the development of dementia and increase survival, we repeated the analysis controlling for use of levodopa and use of selegiline as time-dependent covariates in different models. We performed supplementary analyses designed to evaluate other possible confounders in the association of incident dementia with mortality in PD.…”
Section: Resultsmentioning
confidence: 99%
“…We used criteria for depression modified from the Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition.3 A unified Parkinson's disease rating scale4 score of 3 or more on the depression item was accepted as diagnostic. According to this scale, 0 indicates no depression; 1, periods of sadness or guilt, never sustained for days or weeks; 2, sustained depression (1 week or longer); 3, sustained depression with vegetative symp¬ toms (insomnia, anorexia, weight loss, loss of interest); and 4, sustained depression with vegetative symptoms and suicidal thoughts or intent. Otherwise, depression was defined as a per¬ sistently depressed mood (not a grief reaction, eg, following the death of a spouse) or a feeling of sadness or being "down-inthe-dumps" associated with a loss of interest in usual activities and with vegetative signs and symptoms.…”
Section: Diagnostic Criteriamentioning
confidence: 99%
“…Dementia complicates the course of idiopathic Parkinson's disease (PD) in many patients. The development of dementia in patients with PD limits standard pharmacotherapy of PD,1 affects quality of life,2 contributes to caregiver distress,3 and has been associated with nursing home placement 4. The development of dementia also has been associated with reduced survival in patients with PD 5–7.…”
mentioning
confidence: 99%